Your browser doesn't support javascript.
loading
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis.
Ahluwalia, Amrit Kaur; Inzaule, Seth; Baggaley, Rachel Clare; Vitoria, Marco; Schaefer, Robin; Schmidt, Heather-Marie Ann; Rodolph, Michelle; Giron, Amalia; Jordan, Michael R.
Afiliação
  • Ahluwalia AK; Tufts University School of Medicine, Boston, MA, USA.
  • Inzaule S; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
  • Baggaley RC; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
  • Vitoria M; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
  • Schaefer R; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
  • Schmidt HA; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
  • Rodolph M; UNAIDS Regional Office for Asia and the Pacific, Bangkok, Thailand.
  • Giron A; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
  • Jordan MR; Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, World Health Organization, Geneva, Switzerland.
AIDS ; 36(13): 1897-1898, 2022 11 01.
Article em En | MEDLINE | ID: mdl-36172874

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profilaxia Pré-Exposição Idioma: En Ano de publicação: 2022 Tipo de documento: Article